Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Aug 5, 2021, before the open
10-Q filed Aug 6, 2021, 37 days after period end · 0001171843-21-005648
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $29.20M | $23.31M | $29.58M | $31.52M |
| Net Income | -$410.00K | -$1.58M | -$247.00K | -$1.46M |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.01 |
| -$0.04 |
| -$0.01 |
| -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
